119-HR9418FEDERALIn Committee

Access to Innovative Treatments Act of 2026

Latest action: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Voted: 6/24/2026Source

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.